Advertisement

Topics

Pharmaceutica Limited Company Profile

13:37 EDT 23rd June 2018 | BioPortfolio

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem caused by the rapid evolution of resistance by pathogenic organisms. The company is targeting both human and veterinary applications for its technologies.
The initial focus is to find a solution to the growing problem of antibiotic resistance in bacteria. For more than twenty years, the founders of Pharmaceutica have been searching for a solution to this problem and have discovered certain molecules that are capable of transforming antibiotic resistant bacteria into antibiotic-susceptible bacteria. These molecules, known as Bacterial Transforming Agents, may be combined with existing antibiotics to produce new drugs which are active against antibiotic-resistant bacteria, including methicillin resistant Staphylococcus aureus (‘MRSA’). Such drugs could also be used in first-line treatment of bacterial infections to prevent the emergence of new antibiotic resistance.

Location

Unit 58G Arthur Street Lakeside
Redditch
Worcestershire
B98 8JY
United Kingdom

Contact

Phone: 44 (0) 1527 524050
Fax: 44 (0) 1527 524740
Email: mel@pharma-bta.com


News Articles [73 Associated News Articles listed on BioPortfolio]

Janssen Pharmaceutica to expand production of Sirturo in Russia

Janssen Pharmaceutica, which is part of US healthcare giant Johnson & Johnson (NYSE: JNJ), plans to increase…

Basilea Pharmaceutica GJ-Zahlen 2017: Finanzergebnisse deutlich verbessert

Bad Marienberg - Basilea Pharmaceutica AG (ISIN: CH0011432447, WKN: A0B9GA, Ticker-Symbol: PK5, SIX Swiss Ex: BSLN, NASDAQ OTC-Symbol: BPMUF) gab heute die Finanzergebnisse für das Geschäftsjahr 20....

Basilea Pharmaceutica AG: Basilea names Adesh Kaul as new member of its Management Committee

Basilea Pharmaceutica AG / Basilea names Adesh Kaul as new member of its Management Committee . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the con...

Basilea Pharmaceutica AG: Basilea ernennt Adesh Kaul zum neuen Mitglied der Geschäftsleitung

Basilea Pharmaceutica AG / Basilea ernennt Adesh Kaul zum neuen Mitglied der Geschäftsleitung . Verarbeitet und übermittelt durch Nasdaq Corporate Solutions. Für den Inhalt der Mitteilung ist der E...

Basilea Pharmaceutica AG: Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Argentina by Grupo Biotoscana

Basilea Pharmaceutica AG / Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Argentina by Grupo Biotoscana . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is sole...

Basilea Pharmaceutica AG: Basilea reports clinical phase 3 study start with antibiotic ceftobiprole in skin infections under BARDA contract

Basilea Pharmaceutica AG / Basilea reports clinical phase 3 study start with antibiotic ceftobiprole in skin infections under BARDA contract . Processed and transmitted by Nasdaq Corporate Solution...

Basilea Pharmaceutica (BSLN) - Strength in numbers

Edison Investment Research - Pharmaceutical & healthcare - Basilea Pharmaceutica: Basilea reported a definable FY17, as a multitude of licensing/distribution agreements announced in 2016/17 for launch...

Basilea Pharmaceutica (BPMUF) Presents At Biotech Days, Kepler Cheuvreux - Slideshow

PubMed Articles [60 Associated PubMed Articles listed on BioPortfolio]

SYNTHESIS OF NOVEL 1,4,5,6,7,8-HEXAHYDROQUINOLINES OF POTENTIAL ANTIMICROBIAL ACTIVITY.

A number of 2,3-disubstituted-1-cyclohexyl 4-(3,4-dimethoxyphenyl-1,4,5,6,7,8)-hexahydroquinolines and 5-(3,4-dimethoxyphenyl-10-cyclohexyl-3,4,5,6,7,8,9,10-octahydro)-3H-pyrimido[4,5-b]quinolines wer...

Anti-retroviral drugs: current state and development in the next decade.

The pace of discovery of new antiretroviral (ARV) drugs has slowed, although the efficacy and safety of once-daily fixed dose combinations have been extensively investigated. Several traditional ARV d...

SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL SCREENING OF DIANDRINE A.

Synthesis of a proline-rich cyclic hexapeptide - diandrine A [VI] was accomplished by coupling of tetrapeptide unit Boc-Gly-Pro-Trp-Pro-OH with dipeptide unit Tyr-Phe-OMe followed by cyclization of li...

NEW PYRIDINE AND TRIAZOLOPYRIDINE DERIVATIVES: SYNTHESIS, ANTIMICROBIAL AND ANTIOXIDANT EVALUATION.

A novel series of pyridine and triazolopyridine derivatives have been synthesized (1-17) and characterized on the basis of their elemental analyses and spectral data. In vitro antibacterial, antifunga...

ANTIFUNGAL ACTIVITY OF THE ROOT EXTRACTS OF PULSATILLA PATENS AGAINST CANDIDA GLABRATA.

Plants from the genus of Pulsatilla produce a variety of secondary metabolites with biological activity. These species play a special role in herbal medicine and are used in traditional folk medicine ...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

The objective of this study was to investigate the effect of three different types of occlusive overlays on the drug delivery of Fentanyl Transdermal Systems, 25 mcg/h manufactured for Myl...

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

The objective of this study was to investigate the effect of clinical procedures on the drug delivery of Fentanyl Transdermal Systems, 25 mcg/h manufactured for Mylan Pharmaceuticals Inc. ...

Vaginal Misoprostol Before IUD Insertion in Women With Cesarean Scar

Groups of study: 120 candidates for Cu T 380A IUD insertion were enrolled in the study. They were divided into two groups: Group 1: Sixty women received 600 micrograms of misoprostol vagi...

Companies [90 Associated Companies listed on BioPortfolio]

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG is an independent biopharmaceutical company actively engaged in the discovery and development of innovative drugs for the treatment of bacterial infections, fungal infections ...

Pharmaceutica Limited

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem...

Janssen Pharmaceutica N.V.

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Aurora Biomolecules

Aurora Biomolecules is situated in the heart of Cambridge & specialises in polyclonal antibody production and peptide synthesis for academia, pharmaceutica and industry.anti-GFP antibodiesContract man...

More Information about "Pharmaceutica Limited" on BioPortfolio

We have published hundreds of Pharmaceutica Limited news stories on BioPortfolio along with dozens of Pharmaceutica Limited Clinical Trials and PubMed Articles about Pharmaceutica Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmaceutica Limited Companies in our database. You can also find out about relevant Pharmaceutica Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...


Corporate Database Quicklinks



Searches Linking to this Company Record